If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCizzle Biotech Share News (CIZ)

Share Price Information for Cizzle Biotech (CIZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.00 (0.00%)
Spread: 0.20 (12.50%)
Open: 1.70
High: 1.70
Low: 1.70
Prev. Close: 1.70
CIZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Vela and Cizzle up as Conduit takes NY listing

Thu, 21st Sep 2023 10:49

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Vela Technologies PLC, up 38% at 0.029 pence, 12-month range 0.01p-0.04p. The early stage-focus technology investor says it intends to exercise a put option agreement to sell its economic interest in the commercialisation of the Covid-19 application of AZD1656 for GBP4.0 million. The option was agreed back in April with Conduit Pharmaceuticals Ltd and its prospective parent company Murphy Canyon Acquisition Corp. Murphy shareholders have now approved the merger with Conduit, giving Conduit a Nasdaq listing. Once any closing conditions are waived or satisfied, Vela will exercise the option. Fellow AIM stock Cizzle Biotechnology Holdings PLC also notes Conduit's reversal into a New York listing, and says it plans to exercise its put option to sell its own 5% economic interest and royalty sharing agreement in AZD1656 to treat inflammatory pulmonary and cardiovascular disease. Cizzle's option will be satisfied through the issue of shares in Conduit, to be worth GBP3.3 million. Cizzle shares are up 2.3%.

----------

AIM - LOSERS

----------

Strix Group PLC, down 42% at 53.7p, 12-month range 50.7p-135p. The maker, designer and supplier of kettle safety controls and other components and devices scales back interim dividend to just 0.9p from 2.75p a year before. This is due to its rising debt following the acquisition of Australia-based water systems manufacturer Billi, and caution in light of a high interest rate environment. In the six months to June 30, pretax profit drops 41% to GBP6.8 million from GBP11.6 million a year before. Revenue grows 29% to GBP65.2 million from GBP50.7 million, but this is mostly thanks to the Billi acquisition. CEO Mark Bartlett says the recovery in demand for kettle controls in UK and Germany is slower than anticipated, and a return to normalised growth will take longer.

----------

Harvest Minerals Ltd, down 27% at 1.5p, 12-month range 1.3p-10.7p. The fertiliser producer says fertiliser sales in the six months to June 30 drop by two thirds to USD931,608 from USD2.7 million a year before. Pretax loss doubles to USD1.6 million from USD883,556. Harvest attributes the weaker performance to lower demand and lower pricing for its product. Sells just 7,280 tonnes of its organic fertiliser KP Fertil, down 74% from 28,104 tonnes. "This is attributable to a reduction in volume demand by farmers who are less incentivised to boost production whilst crop prices are low and energy prices are high," says Executive Chair Brian McMaster. Harvest Minerals is positioned to support higher sales volumes and rebuild profit "as and when the market improves", he says. The company's directors temporarily pause drawing remuneration to help reduce the company's cash burn rate.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Dec 2022 18:15

TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
23 Nov 2022 16:58

IN BRIEF: Cizzle Biotechnology signs lung-cancer study in China

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Signs further Memorandum of Understanding with International Co-Innovation Centre for Advanced Medical Technology for a clinical pilot study with the Cancer Hospital Chinese Academy of Medical Sciences, National Cancer Center of China. The clinical pilot study will evaluate optimised assays using a monoclonal antibody that Cizzle Biotechnology has developed that specifically detects CIZ1B, which is highly associated with stage 1 lung cancer.

Read more
9 Nov 2022 20:41

UPDATE: Cizzle, Vela Technologies notes planned Conduit Pharma merger

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - and Vela Technologies PLC - Bradford, England-based investment firm focused on early-stage and pre-IPO disruptive technology investments - Notes announcement by Conduit Pharmaceuticals Ltd that it intends to become a publicly traded company on the Nasdaq in the US through a merger with special purpose acquisition firm Murphy Cannon Acquisition Corp. The deal is expected to generate USD149.7 million worth of proceeds for Conduit.

Read more
28 Sep 2022 14:43

Cizzle Biotechnology reports narrowed loss as passes "key milestones"

(Alliance News) - Cizzle Biotechnology Holdings PLC on Wednesday said it had passed "key milestones" as it moved towards generating revenue for its products.

Read more
18 Aug 2022 11:37

Vela Tech, Cizzle Biotech shares jump on investee's trial results

(Alliance News) - Vela Technologies PLC and Cizzle Biotechnology Holdings PLC on Thursday hailed the latest clinical trial results from investee St George Street Capital Ltd.

Read more
5 Jul 2022 12:15

Cizzle Biotechnology expands use of lung cancer test

(Alliance News) - Cizzle Biotechnology Holdings PLC on Tuesday said that it is using its early-stage lung cancer test technology to detect more cancer types, notably breast cancer.

Read more
20 Jun 2022 15:40

UK shareholder meetings calendar - next 7 days

Tuesday 21 June 
1Spatial PLCAGM
Altus Strategies PLCAGM
Coca-Cola HBC AGAGM
FireAngel Safety Technology Group PLCAGM
HC Slingsby PLCAGM
HSS Hire Group PLCAGM
Mission Group PLCAGM
Novacyt SAAGM
Pendragon PLCAGM
RTW Venture Fund LtdAGM
Velocys PLCAGM
Wednesday 22 June 
ASA International Group PLCAGM
Atalaya Mining PLCAGM
Bonhill Group PLCAGM
Chapel Down Group PLCAGM
Churchill China PLCAGM
Downing Renewables & Infrastructure Trust PLCGM re share issue
Ecofin US Renewables Infrastructure Trust PLCAGM
EJF Investments LtdAGM
Frenkel Topping Group PLCAGM
Good Energy Group PLCAGM
Honeycomb Investment Trust PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Intelligent Ultrasound Group PLCAGM
Iofina PLCAGM
John Wood Group PLCAGM
Kingfisher PLCAGM
LXi REIT PLCGM
Menhaden PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Pennant International Group PLCAGM
Plant Health Care PLCAGM
Skillcast Group PLCAGM
Team PLCAGM
Tribal Group PLCGM re final dividend
Trident Royalties PLCAGM
Vertu Motors PLCAGM
Wentworth Resources PLCAGM
Thursday 23 June 
Avacta Group PLCAGM
Anglo Asian Mining PLCAGM
Card Factory PLCAGM
Cordiant Digital Infrastructure LtdAGM
Downing Renewables & Infrastructure Trust PLCGM re initial placing & open offer
Eight Capital Partners PLCGM re aligning 2022 bonds with 2026 bonds
GENinCode PLCAGM
Ideagen PLCGM re takeover by Hg Pooled Management Ltd
Longboat Energy PLCAGM
Oxford Nanopore Technologies PLCAGM
Puma VCT 13 PLCGM re cancellation of listing & liquidation
RBG Holdings PLCAGM
Tandem Group PLCAGM
Union Jack Oil PLCAGM
Zinnwald Lithium PLCAGM
Friday 24 June 
AFC Energy PLCGM re fees for non-executive directors
Avast PLCAGM
Devolver Digital IncAGM
Entain PLCAGM
Gulf Keystone Petroleum LtdAGM
Hawkwing PLCAGM
Invesco Bond Income Plus LtdAGM
Life Science REITAGM
Northcoders Group PLCAGM
Princess Private Equity Holding LtdAGM
Monday 27 June 
Anglo-Eastern Plantations PLCAGM
Celadon Pharmaceuticals PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Echo Energy PLCAGM
Medica Group PLCAGM
Pelatro PLCAGM
Surgical Innovations Group PLCAGM
Warpaint London PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
16 Jun 2022 16:55

TRADING UPDATES: Valereum opens NFT market; Conygar considers raising

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 May 2022 12:32

IN BRIEF: Cizzle Biotechnology widens annual loss on acquisition costs

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Posts higher annual loss in 2021. Pretax loss widens to GBP4.0 million from GBP14,000 in 2020. In May 2021, Cizzle was bought by Bould Opportunities PLC. Acquisition-related costs stand at GBP3.1 million in 2021 versus none in 2020.

Read more
6 May 2022 11:18

AIM WINNERS & LOSERS: SDI upbeat; Westminster rises on contract win

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
6 May 2022 10:11

Cizzle Biotechnology shares jump on US lung cancer collaboration

(Alliance News) - Cizzle Biotechnology Holdings PLC on Friday announced a new collaboration into lung cancer testing with a US partner.

Read more
11 Apr 2022 21:14

TRADING UPDATES: WANdisco bookings up; STM legal appeal denied

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
8 Mar 2022 06:45

IN BRIEF: Cizzle Biotech notes promising data from Arcadia study

Cizzle Biotechnology Holdings PLC - London-based diagnostics developer - Reports that Arcadia clinical study shows potential value of AZD1656 treatment for Covid-19 patients. The new data analysis comes from St George Street Capital Ltd, which runs the trial with Excalibur Medicines Ltd for the treatment, in which Cizzle holds a "significant" royalty-bearing economic interest.

Read more
14 Feb 2022 15:26

Cizzle Biotechnology acquires further 5% interest in Covid treatment

(Alliance News) - Cizzle Biotechnology Holdings PLC shares jumped on Monday after it announced that it acquired an additional 5% interest in the commercialisation of the Covid-19 treatment AZD 1656.

Read more
3 Feb 2022 22:31

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

TRADING UPDATES: Alliance Pharma to appeal; Braemar sales to rise

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.